Article
A single-cell atlas of IL-23 inhibition in cutaneous psoriasis distinguishes clinical response
26 Jan 2024
Abstract excerpt
Psoriasis vulgaris and other chronic inflammatory diseases improve markedly with therapeutic blockade of interleukin-23 (IL-23) signaling, but the genetic mechanisms underlying clinical responses remain poorly understood. Using single-cell transcriptomics, we profiled immune cells isolated from lesional psoriatic skin before and during IL-23 blockade. In clinically responsive patients, a psoriatic transcriptional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
